Today: 27 June 2026
Snowflake (NYSE:SNOW) finishes up for the week after Russell rebalance trading
27 June 2026
2 mins read

Snowflake (NYSE:SNOW) finishes up for the week after Russell rebalance trading

NEW YORK, June 27, 2026, 11:04 EDT

  • Snowflake Inc jumped 9.65% Friday to finish at $248.96. That flipped what had been a down week through Thursday into a 7.2% gain from the pre-Juneteenth close.
  • Trading volume on Friday hit 25.61 million shares, roughly five times what the stock averaged over the previous four sessions.
  • Monday is the next test, as Russell U.S. index changes kick in and the one-day jump in liquidity rolls off the tape.

Snowflake Inc shares closed at $248.96 on Friday, up 9.65%. The move followed a drop earlier in the week, with the stock sliding from $232.29 on June 18 to $227.06 by Thursday. Trading volume hit 25.61 million, well above the roughly 5.1 million average from the previous four sessions, Investing.com data showed.

Friday capped the week with Snowflake up 7.2% from its June 18 close. The Invesco QQQ Trust slid 4.6% for the week, the iShares Expanded Tech-Software Sector ETF (BATS:IGV) dropped 1.0%, and the SPDR S&P 500 ETF Trust (NYSEARCA:SPY) lost 2.4%.

FTSE Russell’s June 2026 U.S. index rebalancing kicked in after the market closed on Friday. The updated indexes go live at Monday’s open. FTSE Russell said it relied on closing prices from the primary exchanges along with NYSE and Nasdaq closing auctions for the adjustments.

Heavy volume Friday didn’t just come from bets on single stocks. The market had braced for big flows from Russell index reshuffling. Steven DeSanctis, equity analyst at Jefferies, said it was a “really massive trade.” Stephens analyst Melissa Roberts called the day a “key liquidity day.” She put total reconstitution-day trading at roughly $150 billion. Reuters

Snowflake’s stock now faces the test of holding above its recent rebalance range. Between Monday and Thursday, it closed between $225.95 and $230.41. Friday’s move took it higher, with shares nearing a $250 session high. If the stock drops back toward its earlier band, the week’s pop could just point to rebalance-driven liquidity, not fresh demand for software AI stocks.

Snowflake’s story is still about last month’s earnings reset. First-quarter fiscal 2027 product revenue increased 34% to $1.33 billion. Net revenue retention was 126%. The company said 779 customers topped $1 million in trailing 12-month product revenue, up 29%. Remaining performance obligations climbed 38% to $9.21 billion. CEO Sridhar Ramaswamy said, “AI continues to be a powerful tailwind,” while CFO Brian Robins pointed to “raising our full-year product revenue guidance.” SEC

Snowflake set the guide. The company is looking for second-quarter product revenue between $1.415 billion and $1.420 billion. For fiscal 2027, Snowflake raised its product revenue outlook to $5.84 billion, up from $5.66 billion. Last month, Snowflake signed a $6 billion, five-year agreement with Amazon.com Inc ’s AWS. Gil Luria at D.A. Davidson said the Amazon deal “adds another element to the growth path.” Reuters

Macro data is coming back into focus this week. The S&P 500 is up over 7% for the year as big U.S. indexes head into the last week of the first half. But a June jobs reading is set for Thursday and could move rate bets. Doug Huber, deputy chief investment officer with Wealth Enhancement, said a strong jobs print might signal “the economy’s hot” and increase odds of a Fed hike. Reuters

U.S. markets will stay closed Saturday. The NYSE trades 9:30 a.m. to 4 p.m. ET during normal hours, and the 2026 holiday list shows a closure set for Friday, July 3, for Independence Day. That means Snowflake only has four standard sessions left to see if Friday’s finish was just a rebalance or the start of new demand.

Michał Rogucki is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic developments. A graduate of Humboldt University of Berlin, he previously worked in investment research and market analysis before transitioning to financial journalism. He covers the trends and events that matter most to investors worldwide.

Stock Market Today

  • Telix Pharmaceuticals and Two Australian Insider-Led Growth Stocks Highlighted
    June 27, 2026, 11:07 AM EDT. Telix Pharmaceuticals (ASX:TLX), a A$5.2 billion biopharmaceutical firm specializing in radiopharmaceuticals for cancer imaging and treatment, draws growth-focused investors despite ongoing losses. The company reported US$621.9 million revenue from Precision Medicine and relies heavily on its oncology pipeline with products like Illuccix and late-stage candidates TLX591 and TLX101. Key risks include high R&D costs, regulatory scrutiny, pricing pressures, and trial dependencies. Also featured are two Australian insider-led growth stocks identified by the Fast Growing Stocks With High Insider Ownership screener, highlighting firms with aligned management-shareholder interests amid mixed inflation and cautious central bank policies.

Latest articles

Snowflake (NYSE:SNOW) finishes up for the week after Russell rebalance trading

Snowflake (NYSE:SNOW) finishes up for the week after Russell rebalance trading

27 June 2026
Snowflake Inc (NYSE:SNOW) surged 9.65% to $248.96 on Friday with trading volume five times the weekly average, driven by FTSE Russell’s U.S. index reconstitution, turning a negative week into a 7.2% gain since June 18, as investors await whether the stock can hold above its previous $225.95–$230.41 range when index-driven liquidity fades next week.
GameStop (NYSE:GME) holds close to cash levels after company guides for $600 million in EBITDA

GameStop (NYSE:GME) holds close to cash levels after company guides for $600 million in EBITDA

27 June 2026
GameStop surged 3.57% to $21.76 and jumped after hours as it forecast FY2026 adjusted EBITDA above $600 million, nearly doubling from 2025; with a $9.76 billion market cap now close to its $9.7 billion in cash, securities, digital assets, and collateral, investors are weighing whether GameStop’s cash-rich balance sheet can support equity while Ryan Cohen pursues an eBay bid.
ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

27 June 2026
ImmunityBio surged 11.8% to $8.71 on Friday with volume tripling its average, as Russell index reconstitution took effect; Monday’s trading will reveal if demand persists or if the spike was driven by index flows, with no imminent company events and recent insider selling accounting for just 0.06% of Friday’s volume.
Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

27 June 2026
Lucid surged 15.6% Friday, adding $312 million in equity value—almost double the $158 million in annualized savings from this week’s restructuring plan that cut 18% of its U.S. workforce. Friday’s volume equaled 54% of reported short interest, but the rally outpaced cost-cutting fundamentals, leaving less room for further gains based solely on headcount cuts.
GameStop (NYSE:GME) holds close to cash levels after company guides for $600 million in EBITDA
Previous Story

GameStop (NYSE:GME) holds close to cash levels after company guides for $600 million in EBITDA

Go toTop